![Precisely Engineering The Future Of Ophthalmology.]()
RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2016 /PRNewswire/ -- Envisia Therapeutics today announced that Dr. Thomas R. Walters, MD will present breakthrough clinical data for Envisia's ENV515 (travoprost XR) glaucoma program at the American Academy of Ophthalmology (AAO) Annual Meeting being...